BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16268803)

  • 1. Macroprolactin does not contribute to elevated levels of prolactin in patients on renal replacement therapy.
    Yavuz D; Topçu G; Ozener C; Akalin S; Sirikçi O
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):520-4. PubMed ID: 16268803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins.
    Ram S; Harris B; Fernando JJ; Gama R; Fahie-Wilson M
    Ann Clin Biochem; 2008 May; 45(Pt 3):256-9. PubMed ID: 18482912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macroprolactin; high molecular mass forms of circulating prolactin.
    Fahie-Wilson MN; John R; Ellis AR
    Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels and peritoneal loss of prolactin in CAPD patients.
    Kagan A; Gertler A; Ulman M; Bar-Khayim Y
    Adv Perit Dial; 1991; 7():247-52. PubMed ID: 1680437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of renal replacement therapies on serum gastrointestinal system hormones.
    Borazan A; Cavdar Z; Saglam F
    Ren Fail; 2007; 29(8):1019-23. PubMed ID: 18067050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroprolactin(s): composition and reactivity in immunoassays and laboratory interpretation of results of an unusual patient serum.
    Ellis AR; Fahie-Wilson M; Axcell M; Sands K; Hill RP
    Ann Clin Biochem; 2006 Jan; 43(Pt 1):57-62. PubMed ID: 16390610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroprolactin: what is it and what is its importance?
    Sadideen H; Swaminathan R
    Int J Clin Pract; 2006 Apr; 60(4):457-61. PubMed ID: 16620360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life of patients having renal replacement therapy.
    Niu SF; Li IC
    J Adv Nurs; 2005 Jul; 51(1):15-21. PubMed ID: 15941456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronobiological variations of prolactin (PRL) in chronic renal failure (CRF).
    Biasioli S; Mazzali A; Foroni R; D'Andrea G; Feriani M; Chiaramonte S; Cesaro A; Micieli G
    Clin Nephrol; 1988 Aug; 30(2):86-92. PubMed ID: 3180518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
    Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients.
    Riegersperger M; van Houte M; Födinger M; Wojcik J; Hörl WH; Winkelmayer WC; Sunder-Plassmann G
    Am J Nephrol; 2007; 27(4):390-6. PubMed ID: 17587788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
    Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
    Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of serum and urinary neopterins in patients with chronic renal disease.
    Godai K; Uemasu J; Kawasaki H
    Clin Nephrol; 1991 Sep; 36(3):141-6. PubMed ID: 1934670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
    Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pretransplant serum cytokine levels in renal transplant recipients.
    Berber I; Yiğit B; Işitmangil G; Tellioğlu G; Ozgezer T; Gülle S; Türkmen F; Titiz I
    Transplant Proc; 2008; 40(1):92-3. PubMed ID: 18261555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.